Literature DB >> 7016180

Covalent structure of collagen: amino acid sequence of alpha 1(III)-CB9 from type III collagen of human liver.

J M Seyer, A H Kang.   

Abstract

The peptide alpha 1(III)-CB9 was prepared and purified from human liver, and its amino acid sequence was determined. Automated Edman degradation of the intact peptide and peptides derived from selective cleavage with hydroxylamine and digestions with trypsin, thermolysin, and Staph V8 protease enabled determination of the complete amino acid sequence. The peptide alpha 1(III)-CB9 represents the COOH terminus of the helical (pepsin-resistant) portion of type III collagen and terminates in a Cys-Cys sequence responsible for the intramolecular disulfide cross-linkages with other chains. The present work completes the entire amino acid sequence of the helical (pepsin-resistant) portion of human cirrhotic liver type III collagen consisting of peptides alpha 1-(III)-CB3-7-6-1-8-10-2-4-5-9. The COOH terminus of human liver alpha 1(III) contained two additional triplets which, together with the extra triplet at the NH2 terminus in alpha 1(III)-CB3, make the helical portion of type III collagen longer than alpha 1(I) by nine residues (three Gly-X-Y triplets). The helical region of human liver type III collagen, therefore, consists of 1023 amino acids or 341 triplets.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016180     DOI: 10.1021/bi00512a040

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Identification of Clostridium histolyticum collagenase hyperreactive sites in type I, II, and III collagens: lack of correlation with local triple helical stability.

Authors:  M F French; A Bhown; H E Van Wart
Journal:  J Protein Chem       Date:  1992-02

2.  A synthetic peptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation.

Authors:  T M Chiang; A H Kang
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Peptide analysis of collagen produced from cDNA by transcription and translation in vitro.

Authors:  J F Bateman; S Lamande; D Chan; W G Cole
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

4.  Collagen gene construction and evolution.

Authors:  B Runnegar
Journal:  J Mol Evol       Date:  1985       Impact factor: 2.395

5.  Isolation and characterization of a human collagen alpha 1(I)-like gene from a cosmid library.

Authors:  E H Weiss; K S Cheah; F G Grosveld; H H Dahl; E Solomon; R A Flavell
Journal:  Nucleic Acids Res       Date:  1982-03-25       Impact factor: 16.971

6.  Comprehensive mass spectrometric mapping of the hydroxylated amino acid residues of the α1(V) collagen chain.

Authors:  Chenxi Yang; Arick C Park; Nicholas A Davis; Jason D Russell; Byoungjae Kim; David D Brand; Matthew J Lawrence; Ying Ge; Michael S Westphall; Joshua J Coon; Daniel S Greenspan
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

7.  Location of 3-hydroxyproline residues in collagen types I, II, III, and V/XI implies a role in fibril supramolecular assembly.

Authors:  Mary Ann Weis; David M Hudson; Lammy Kim; Melissa Scott; Jiann-Jiu Wu; David R Eyre
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

8.  A conserved nucleotide sequence, coding for a segment of the C-propeptide, is found at the same location in different collagen genes.

Authors:  Y Yamada; K Kühn; B de Crombrugghe
Journal:  Nucleic Acids Res       Date:  1983-05-11       Impact factor: 16.971

9.  Molecular cloning and carboxyl-propeptide analysis of human type III procollagen.

Authors:  H R Loidl; J M Brinker; M May; T Pihlajaniemi; S Morrow; J Rosenbloom; J C Myers
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

10.  Human alpha 1(III) and alpha 2(V) procollagen genes are located on the long arm of chromosome 2.

Authors:  B S Emanuel; L A Cannizzaro; J M Seyer; J C Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.